HbA@c was @mmol/mol ( @ % CI @ , @ ) at the end of the SC treatment phase in @ , @mmol/mol ( @ % CI @ , @ ) at the end of the CIPII treatment phase and @mmol/mol ( @ % CI @ , @ ) in @ , respectively ( p > @ ) .